aTyr Pharma: Q2 Earnings Insights



aTyr Pharma LIFE reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


aTyr Pharma missed estimated earnings by 15.79%, reporting an EPS of $-0.44 versus an estimate of $-0.38.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 3.06% drop in the share price the next day.

Here's a look at aTyr Pharma's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.33 -0.28 -0.60 -0.51
EPS Actual -0.44 -0.31 -0.42 -0.64
Revenue Estimate 170K 3.02M 230K 620K
Revenue Actual 0 0 0 0

To track all earnings releases for aTyr Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!